Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CD328/SIGLEC7 Antibody (R3X65)

Catalog #:   RHJ85502 Specific References (10) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, IHC
Accession: Q9Y286
Overview

Catalog No.

RHJ85502

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400, IHC: 1:200-1:1000

Target

QA79 membrane protein, Adhesion inhibitory receptor molecule 1, D-siglec, CDw328, Siglec-7, p75, SIGLEC7, AIRM-1, Sialic acid-binding Ig-like lectin 7, CD328, AIRM1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9Y286

Applications

ELISA, FCM, IHC

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3X65

Data Image
  • Flow Cytometry
    Flow cytometric analysis of HL-60 cells using CD328 mouse mAb (green) and negative control (red).
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human lung cancer tissues using CD328 mouse mAb with DAB staining.
References

Effect of Hypoxia on Siglec-7 and Siglec-9 Receptors and Sialoglycan Ligands and Impact of Their Targeting on NK Cell Cytotoxicity., PMID:39598355

Soluble and Immobilized Anti-CD3/28 Distinctively Expand and Differentiate Primary Human T Cells: An Implication for Adoptive T Cell Therapy., PMID:36640054

Exosomal CD73 from serum of patients with melanoma suppresses lymphocyte functions and is associated with therapy resistance to anti-PD-1 agents., PMID:35273100

Chrysophanol Mitigates T Cell Activation by Regulating the Expression of CD40 Ligand in Activated T Cells., PMID:32854357

Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody-Activated Chimeric Antigen Receptor-Modified T Cells., PMID:28550199

Avoiding phagocytosis-related artifact in myeloid derived suppressor cell T-lymphocyte suppression assays., PMID:27856191

T-cell receptor/CD28-mediated activation of human T lymphocytes induces expression of functional mu-opioid receptors., PMID:18463202

Blockade of CD11a by efalizumab in psoriasis patients induces a unique state of T-cell hyporesponsiveness., PMID:18239614

Quantitative assessment of human T lymphocytes in RAG2(-/-)gammac(-/-) mice: the impact of ex vivo manipulation on in vivo functionality., PMID:17198880

Human CD8+ T cells do not require the polarization of lipid rafts for activation and proliferation., PMID:12419850

Datasheet
$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CD328/SIGLEC7 Antibody (R3X65) [RHJ85502]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only